Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015;16(2):187-8.
doi: 10.1080/15384047.2014.1002368.

Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'

Comment

Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'

Vincenzo Formica et al. Cancer Biol Ther. 2015.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
survival curves schematically representing original results of GOG 240 trial.
Figure 2.
Figure 2.
survival curves schematically representing original results of GOG 240 trial with hypothetic quantification of real benefit from bevacizumab addition.

Comment on

  • Improved survival with bevacizumab in advanced cervical cancer.
    Tewari KS, Sill MW, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ. Tewari KS, et al. N Engl J Med. 2014 Feb 20;370(8):734-43. doi: 10.1056/NEJMoa1309748. N Engl J Med. 2014. PMID: 24552320 Free PMC article. Clinical Trial.

References

    1. Goey AK, Figg WD. Potential novel role of bevacizumab in glioblastoma and cervical cancer. Cancer Biol Ther 2014. Oct; 15(10):1296-8; Epub 2014 Jul 21; PMID:25046485; http://dx.doi.org/ 10.4161/cbt.29926 - DOI - PMC - PubMed
    1. Tewari KS, Sill MW, Long HJ, 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 2014; 370:734-43; PMID:24552320; http://dx.doi.org/ 10.1056/NEJMoa1309748 - DOI - PMC - PubMed

MeSH terms

Substances